Weisblum Eric
Chief Executive Officer
Weisblum Eric has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Dec 16, 2025.
On the most recent filing, Weisblum Eric is listed as Chief Executive Officer at Silo Pharma, Inc. Inside the rolling window, Weisblum Eric reported 5 open-market purchases totaling $8K in SILO and no open-market sales. The largest disclosed transaction in the window is a purchase of 7,500 SILO shares on Nov 18, 2025, worth $3K.
Companies traded
Insider Buying
$8K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Weisblum Eric made?
Weisblum Eric has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Weisblum Eric trade?
Weisblum Eric has filed SEC Form 4 disclosures for 1 company, including SILO.
When was Weisblum Eric's most recent SEC Form 4 filing?
Weisblum Eric's most recent SEC Form 4 filing on Tracefour is dated Dec 16, 2025.
What is Weisblum Eric's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Weisblum Eric is listed as Chief Executive Officer.
What is Weisblum Eric's total buy and sell value in the current window?
Inside the rolling retention window, Weisblum Eric bought $8K and sold $0 based on SEC Form 4 filings.
What was Weisblum Eric's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 7,500 SILO shares on 2025-11-18, worth $3K, per SEC Form 4 filings.